Results 201 to 210 of about 34,512 (245)

Ex Vivo Experiments Show That IDH1/2-Mutant Inhibitors Can be Safely Used As Adjuvants to Regular Chemotherapy in IDH1/2-Mutated Acute Myeloid Leukemia

open access: bronze, 2015
Remco J. Molenaar   +9 more
openalex   +1 more source

mtKO: A dedicated guide RNA library for mitochondria research. [PDF]

open access: yesProc Natl Acad Sci U S A
Kaur K   +9 more
europepmc   +1 more source

Analysis of IDH1 and IDH2 mutations as causes of the hypermethylator phenotype in colorectal cancer. [PDF]

open access: yesJ Pathol
Ward JC   +22 more
europepmc   +1 more source

Targeted and epigenetic therapies for acute myeloid leukemia treatment. [PDF]

open access: yesDiscov Oncol
Shokoohi M   +5 more
europepmc   +1 more source

Proteomic Tracking Extracellular Vesicle RNA Interactors in Recipient Immune Cells through Orthogonal Labelings. [PDF]

open access: yesJ Am Chem Soc
Zhang Z   +10 more
europepmc   +1 more source

Cancer Metabolism: Aspirations for the Coming Decade. [PDF]

open access: yesCold Spring Harb Perspect Med
DeBerardinis RJ, Vousden KH, Chandel NS.
europepmc   +1 more source

Tissue mechanics promote IDH1-dependent HIF1α–tenascin C feedback to regulate glioblastoma aggression

open access: green, 2016
Yekaterina A. Miroshnikova   +12 more
openalex   +2 more sources

Home - About - Disclaimer - Privacy